Solid Biosciences Inc. (SLDB): Depreciation & Amortization
$1.64M
Year ended 2025-12-31
$1.63M
Trailing 12 months to 2026-06-30
-12.1%
3-year compound annual growth
-16.0%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.64M | -33.4% | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | $2.46M | -4.9% | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | $2.58M | +7.2% | 2025-03-06, From 2023-01-01 |
| 2022-12-31 | $2.41M | -18.8% | 2024-03-13, From 2022-01-01 |
| 2021-12-31 | $2.96M | -24.4% | 2024-03-13, From 2021-01-01 |
| 2020-12-31 | $3.92M | +38.9% | 2023-03-23, From 2020-01-01 |
| 2019-12-31 | $2.82M | n/a | 2022-03-14, From 2019-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Solid Biosciences Inc. (SLDB) | 2025-12-31 | $1.64M | -33.4% |
| DBV Technologies S.A. (DBVT) | 2025-12-31 | $2.99M | +9.8% |
| TScan Therapeutics, Inc. (TCRX) | 2025-12-31 | $2.90M | -29.3% |
| Agenus Inc (AGEN) | 2025-12-31 | $10.00M | -25.1% |
| enGene Therapeutics Inc. (ENGN) | 2025-10-31 | $500.0K | +66.7% |
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | $12.54M | -2.2% |
| Compass Therapeutics, Inc. (CMPX) | 2025-12-31 | $276.0K | -53.1% |
| Coherus Oncology, Inc. (CHRS) | 2025-12-31 | $3.92M | -25.6% |
| Tectonic Therapeutic, Inc. (TECX) | 2025-12-31 | $1.38M | -16.4% |
Compare SLDB, DBVT, TCRX, AGEN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗